@ShiningScience
🚨Scientists just reprogrammed leukemia to self-destruct – and it worked. In a major breakthrough, scientists at Institut Pasteur have developed a therapy that forces leukemia cells to self-destruct—and alerts the immune system to wipe out the rest. The team targeted malignant B-cell leukemia with a triple-drug combination that reprograms cancer cells to undergo necroptosis, a form of inflammatory cell death. Unlike the silent shutdown of apoptosis, necroptosis creates an immune alarm, drawing in the body's defenses. Using real-time imaging, researchers watched immune cells swarm the cancer, leading to total tumor elimination in lab models. The challenge was that B-cell cancers typically lack a key protein, MLKL, needed for necroptosis. But the team cleverly sidestepped this using three existing clinical drugs. Together, they bypassed the missing protein and reactivated necroptotic pathways. The result: not just tumor shrinkage, but complete disappearance in multiple preclinical models. While human trials are still to come, the findings hint at a new kind of cancer therapy—one that doesn’t just kill tumors, but trains the immune system to join the fight. And because the drugs are already approved, the road to real-world use could be much shorter. Source: Le Cann, F., et al. (2025). Reprogramming RIPK3-induced cell death in malignant B cells promotes immune-mediated tumor control. Science Advances.
